C-reactive protein and long-term ischemic stroke prognosis

Journal of Clinical Neuroscience

Volumn 21, Issue 4, 2014, Pages 547-553

  Vangilder, Reyna L ^a,b   Davidov, Danielle M ^b   Stinehart, Kyle R ^b   Huber, Jason D ^b   Turner, Ryan C ^b   Wilson, Karen S ^c   Haney, Eric ^c   Davis, Stephen M ^b   Chantler, Paul D ^c   Theeke, Laurie ^a   Rosen, Charles L ^b   Crocco, Todd J ^b   Gutmann, Laurie ^b   Barr, Taura L ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF NURSING   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

C reactive protein; CRP; Functional recovery; Ischemic stroke; Neuroimaging; Outcome after stroke; Prognosis

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

BRAIN ISCHEMIA; CONVALESCENCE; DISEASE DURATION; FUNCTIONAL STATUS; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; REVIEW; BLOOD; STROKE;

BIOLOGICAL MARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; HUMANS; PROGNOSIS; RECOVERY OF FUNCTION; STROKE;

EID: 84896079703     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.06.015     Document Type: Review

References (47)

1. Prevalence of stroke - United States, 2006-2010 MMWR Morb Mortal Wkly Rep 61 2012 379 382
2. K. Asplund, B. Stegmayr, and M. Peltonen From the twentieth to the twenty-first century: a public health perspective M.D. Ginsberg, J. Bogousslavsky, Cerebrovascular disease: pathophysiology, diagnosis, and management 1998 Blackwell Science
3. D. Lloyd-Jones, R.J. Adams, and T.M. Brown et al. Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 948 954
4. P. Calabro, E. Golia, and E.T. Yeh Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches Curr Pharm Biotechnol 13 2012 4 16
5. K.H. Allin, and B.G. Nordestgaard Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer Crit Rev Clin Lab Sci 48 2011 155 170
6. N. Amemiya, T. Ogawa, and K. Otsuka et al. Comparison of serum albumin, serum C-reactive protein, and pulse wave velocity as predictors of the 4-year mortality of chronic hemodialysis patients J Atheroscler Thromb 18 2011 1071 1079
7. T.T. Idicula, J. Brogger, and H. Naess et al. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study' BMC Neurol 9 2009 18
8. S. Kaptoge, E. Di Angelantonio, and G. Lowe et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 2010 132 140
9. B.D. Schaan, L.C. Pellanda, and P.T. Maciel et al. C-reactive protein in acute coronary syndrome: association with 3-year outcomes Braz J Med Biol Res 42 2009 1236 1241
10. C. Iadecola, and J. Anrather The immunology of stroke: from mechanisms to translation Nat Med 17 2011 796 808
11. S.H. Oh, O.J. Kim, and D.A. Shin et al. Alteration of immunologic responses on peripheral blood in the acute phase of ischemic stroke: blood genomic profiling study J Neuroimmunol 249 2012 60 65
12. T. Anuk, E.B. Assayag, and R. Rotstein et al. Prognostic implications of admission inflammatory profile in acute ischemic neurological events Acta Neurol Scand 106 2002 196 199
13. L.S. Rallidis, M. Vikelis, and D.B. Panagiotakos et al. Inflammatory markers and in-hospital mortality in acute ischaemic stroke Atherosclerosis 189 2006 193 197
14. A.R. Nayak, R.S. Kashyap, and D. Kabra et al. Time course of inflammatory cytokines in acute ischemic stroke patients and their relation to inter-alfa trypsin inhibitor heavy chain 4 and outcome Ann Indian Acad Neurol 15 2012 181 185
15. T.L. Barr, L.L. Latour, and K.Y. Lee et al. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9 Stroke 41 2010 e123 e128
16. J. Kim, T.J. Song, and J.H. Park et al. Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction Atherosclerosis 222 2012 464 467
17. J. Yan, S.J. Read, and R.D. Henderson et al. Frequency and function of regulatory T cells after ischaemic stroke in humans J Neuroimmunol 243 2012 89 94
18. M. Di Napoli, M. Schwaninger, and R. Cappelli et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members Stroke 36 2005 1316 1329
19. C.S. Kidwell, and S. Warach Acute ischemic cerebrovascular syndrome: diagnostic criteria Stroke 34 2003 2995 2998
20. N. Hasan, P. McColgan, and P. Bentley et al. Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review Br J Clin Pharmacol 74 2012 230 240
21. K. Rajeshwar, S. Kaul, and A. Al-Hazzani et al. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome Inflammation 35 2012 978 984
22. L.M. McShane, D.G. Altman, and W. Sauerbrei et al. REporting recommendations for tumour MARKer prognostic studies (REMARK) Br J Cancer 93 2005 387 391
23. W. Whiteley, W.L. Chong, and A. Sengupta et al. Blood markers for the prognosis of ischemic stroke: a systematic review Stroke 40 2009 e380 e389
24. P.A. Kyzas, K.T. Loizou, and J.P. Ioannidis Selective reporting biases in cancer prognostic factor studies J Natl Cancer Inst 97 2005 1043 1055
25. S. Mallett, A. Timmer, and W. Sauerbrei et al. Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines Br J Cancer 102 2010 173 180
26. L. Marquardt, A. Ruf, and U. Mansmann et al. Inflammatory response after acute ischemic stroke J Neurol Sci 236 2005 65 71
27. K. Winbeck, H. Poppert, and T. Etgen et al. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke Stroke 33 2002 2459 2464
28. J. Montaner, I. Fernandez-Cadenas, and C.A. Molina et al. Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis Stroke 37 2006 1205 1210
29. I.U. Song, Y.D. Kim, and J.S. Kim et al. Can high-sensitivity C-reactive protein and plasma homocysteine levels independently predict the prognosis of patients with functional disability after first-ever ischemic stroke? Eur Neurol 64 2010 304 310
30. C.S. Kidwell, J.A. Chalela, and J.L. Saver et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage JAMA 292 2004 1823 1830
31. S. Prabhakaran, A.J. Silver, and L. Warrior et al. Misdiagnosis of transient ischemic attacks in the emergency room Cerebrovasc Dis 26 2008 630 635
32. H. Worthmann, A.B. Tryc, and A. Goldbecker et al. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome Cerebrovasc Dis 30 2010 85 92
33. J. Montaner, M. Mendioroz, and P. Delgado et al. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway J Proteomics 75 2012 4758 4765
34. S.A. Roudbary, F. Saadat, and K. Forghanparast et al. Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke Acta Med Iran 49 2011 149 152
35. M.R. Gaudinski, E.C. Henning, and A. Miracle et al. Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant Stroke 39 2008 2765 2768
36. G. Sulter, C. Steen, and J. De Keyser Use of the Barthel index and modified Rankin scale in acute stroke trials Stroke 30 1999 1538 1541
37. H.P. Adams Jr, R.F. Woolson, and J. Biller et al. Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group Haemostasis 22 1992 99 103
38. L. Govan, P. Langhorne, and C.J. Weir Categorizing stroke prognosis using different stroke scales Stroke 40 2009 3396 3399
39. O.Y. Bang, H.Y. Park, and J.H. Yoon et al. Predicting the long-term outcome after subacute stroke within the middle cerebral artery territory J Clin Neurol 1 2005 148 158
40. W.K. Seo, H.Y. Seok, and J.H. Kim et al. C-Reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke J Stroke Cerebrovasc Dis 21 2012 181 186
41. H. Adams, R. Adams, and G. Del Zoppo et al. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association Stroke 36 2005 916 923
42. T.L. Barr, Y. Conley, and J. Ding et al. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling Neurology 75 2010 1009 1014
43. G.C. Jickling, and F.R. Sharp Blood biomarkers of ischemic stroke Neurotherapeutics 8 2011 349 360
44. M. Di Napoli, and F. Papa Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke Stroke 34 2003 2922 2929
45. B.M. Everett, R.J. Glynn, and J.G. MacFadyen et al. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) Circulation 121 2010 143 150
46. K. Prasad C-reactive protein (CRP)-lowering agents Cardiovasc Drug Rev 24 2006 33 50
47. A. Liberati, D.G. Altman, and J Tetzlaff et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6 2009 e1000100